(Q36835821)

16 August 2017

1 reference

title

Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment (English)

1 reference

16 August 2017

1 reference

Haas DW

1

1 reference

PubMed ID

8948280

16 August 2017

McAndrew MP

series ordinal

2

1 reference

PubMed ID

8948280

16 August 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

American Journal of Medicine

16 August 2017

1 reference

16 August 2017

101

1 reference

16 August 2017

5

1 reference

16 August 2017

550-561

1 reference

Osteomyelitis: A Review of Clinical Features, Therapeutic Considerations and Unusual Aspects

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects (second of three parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Osteomyelitis: the past decade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Acute pubic osteomyelitis in athletes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Experimental Osteomyelitis. I. A Description of the Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Biomaterial-centered infection: microbial adhesion versus tissue integration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Long-term results of prophylactic cefazolin versus placebo in total hip replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Selective binding of bone matrix sialoprotein to Staphylococcus aureus in osteomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Osteomyelitis due to Pseudallescheria boydii.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

PASTEURELLA MULTOCIDA INFECTIONS. A REPORT OF SIX CASES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Aerobic and anaerobic bacteria in diabetic foot ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Bacteriology of 100 consecutive diabetic foot infections and in vitro susceptibility to ampicillin/sulbactam versus cefoxitin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

7 January 2021

Anaerobic osteomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

The scintigraphic diagnosis of osteomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Abnormal radionuclide deposition patterns adjacent to focal skeletal lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Diagnosis of Osteomyelitis in Children by Combined Blood Pool and Bone Imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Radionclide imaging in skeletal inflammatory and ischemic disease in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Diagnosis of bone and joint infection by leucocyte scintigraphy. A comparative study with 99mTc-HMPAO-labelled leucocytes, 99mTc-labelled antigranulocyte antibodies and 99mTc-labelled nanocolloid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Unsuspected Osteomyelitis in Diabetic Foot Ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Detection of osteomyelitis at fracture nonunion sites: comparison of two scintigraphic methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Vertebral osteomyelitis: assessment using MR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Erythrocyte sedimentation rate in infected and non-infected total-hip arthroplasties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Enzyme-linked immunosorbent assay for the detection of antibodies to exocellular proteins of Staphylococcus aureus in bone infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Diagnostic value of sinus-tract cultures in chronic osteomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Diagnostic strategies in osteomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Brief report: disseminated osteomyelitis from Mycobacterium ulcerans after a snakebite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Randomized evaluation of ceftazidime or ticarcillin and tobramycin for the treatment of osteomyelitis caused by gram-negative bacilli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Ofloxacin versus parenteral therapy for chronic osteomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Experimental Osteomyelitis. IV. Therapeutic Trials with Rifampin Alone and in Combination with Gentamicin, Sisomicin, and Cephalothin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Experimental chronic staphylococcal osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Clindamycin treatment of experimental chronic osteomyelitis due to Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Oral antimicrobial therapy for osteomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Oral quinolone treatment for osteomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

How often is medication taken as prescribed? A novel assessment technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Compliance declines between clinic visits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Assessment of bone viability in patients with osteomyelitis: preliminary clinical experience with laser Doppler flowmetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

A quantitative analysis of donor site morbidity after vascularized fibula transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Donor site morbidity following osteocutaneous free fibula transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Antibiotic beads in the management of surgical infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

The sustained release of cefotaxim from a fibrin-cefotaxim compound in treatment of osteitis. Pharmacokinetic study and clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

[Treatment of chronic osteomyelitis with a collagen-antibiotic compound--preliminary report]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Mechanical properties of bone cements containing large doses of antibiotic powders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

The effect of antibiotic additions on the mechanical properties of acrylic cement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Management of deep infection of total hip replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Gentamicin-PMMA beads in the treatment of chronic osteomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

HYPERBARIC OXYGENATION CHRONIC OSTEOMYELITIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

EFFECTS OF HYPERBARIC OXYGEN ON SOME COMMON PATHOGENIC BACTERIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Experimental effects of hyperbaric oxgen on selected clostridial species. I. In-vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Use of hyperbaric oxygen in the treatment of refractory osteomyelitis: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Adjunctive hyperbaric oxygen therapy in the treatment of chronic refractory osteomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

Quantitative aerobic and anaerobic bacteriology of infected diabetic feet.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

7 January 2021

Anaerobic bacteria in bone and joint infections

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

7 January 2021

The diagnostic value of C-reactive protein in infected total hip arthroplasties

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

7 January 2021

Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

7 January 2021

Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

7 January 2021

Deep infection in Charnley low-friction arthroplasty. Comparison of plain and gentamicin-loaded cement

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900260-4

7 January 2021

10.1016/S0002-9343(96)00260-4

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

8948280